NDC 55289-920-98
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-920
- Requested NDC
- 55289-920-98
- Package NDCs from labels
- 55289-920-98
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-920-06 | EA - Each | 55289-920 | 706d0221-1af2-41d4-9df2-bf37b14b690f | 1 | 2012-07-24 |
| 55289-920-30 | EA - Each | 55289-920 | 29427292-7c0b-4173-859f-ff32c417f2e7 | 1 | 2012-07-24 |
| 55289-920-40 | EA - Each | 55289-920 | 27fb6d9e-1de6-4d20-a60e-6518e959ca62 | 1 | 2012-07-24 |
| 55289-920-60 | EA - Each | 55289-920 | d88ef8cb-70eb-456a-8133-6265354cbc4a | 1 | 2012-07-24 |
| 55289-920-90 | EA - Each | 55289-920 | cd4fb9c8-ca98-40b2-8d76-5faca8c9fb4e | 1 | 2012-07-24 |
| 55289-920-98 | EA - Each | 55289-920 | 2a336a9c-9f8d-4b3f-8c19-cc8e37318b9d | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lithium Carbonate | LITHIUM CARBONATE | PD-Rx Pharmaceuticals, Inc. | edfceebd-a3e4-4905-bffe-cdc0b948dcd2 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Zaleplon | ZALEPLON | PD-Rx Pharmaceuticals, Inc. | a1277ef5-6072-43ff-a6ce-0a7cea58b7cb | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2df111dc-ecac-4161-9e22-38436eb37c1f | 2025-10-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Amoxicillin | AMOXICILLIN | PD-Rx Pharmaceuticals, Inc. | 987786a1-d748-4b42-abb5-62a2f38ef195 | 2025-10-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| NAPROXEN | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | a9f9ce81-9d51-4167-9581-974866a8fe31 | 2025-10-17 | Warnings | PD-Rx Pharmaceuticals, Inc. |
| Metoprolol Tartrate | METOPROLOL TARTRATE | PD-Rx Pharmaceuticals, Inc. | f4a4da81-c4d0-4a00-9f08-9029b5d9b5ea | 2025-10-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Clarithromycin | CLARITHROMYCIN | PD-Rx Pharmaceuticals, Inc. | 1d328f5d-73c1-4df7-a3df-71d0e0221181 | 2025-10-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 4789b7ae-314c-43c0-ad33-92ff50085f27 | 2025-10-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Tamsulosin Hydrochloride | TAMSULOSIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | f6b6aeab-bedd-4254-8811-4f65cf8a351f | 2025-10-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Atenolol | ATENOLOL | PD-Rx Pharmaceuticals, Inc. | 8acdb229-928b-4c22-88f1-f4dd97cde274 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Cefdinir | CEFDINIR | PD-Rx Pharmaceuticals, Inc. | e296387e-eb20-4451-a184-f91748a4e9c7 | 2025-10-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 1a3e389f-391d-4f37-9e34-ce3c6f5fe8c1 | 2025-10-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | f115ad6d-cf62-40e7-89d1-6183a9b5071f | 2025-10-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Cefdinir | CEFDINIR | PD-Rx Pharmaceuticals, Inc. | f4f62b64-5350-4b4e-b8f2-381f54a0cd10 | 2025-10-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Diazepam | DIAZEPAM | PD-Rx Pharmaceuticals, Inc. | 2483426d-3782-432a-8b8d-86c06ef0de4a | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Diazepam | DIAZEPAM | PD-Rx Pharmaceuticals, Inc. | 84cecab3-d0e6-436b-996b-0b598e972308 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | PD-Rx Pharmaceuticals, Inc. | ceddc406-4a17-471f-917e-63b4b03779ea | 2025-10-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Famotidine | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | 66f0bf15-ff35-426a-b40c-0d0da79d0861 | 2025-10-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 7842eeab-decf-47e7-9134-0add90549a3d | 2025-10-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Famotidine | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | 09ef39a4-c6b3-4395-8211-3f551dc44830 | 2025-10-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.